menu
    • menu

    Company profile for Harm Reduction Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health. Our Mission is to prevent opioid overdose deaths by making naloxone available to everyone at a low price. A nonprofit pharmaceutical company will not be a panacea for America’s opioid crisis, nor for the ongoing struggle with the high prices of many drugs. Indeed, for-profit pharmaceutical companies...
    Harm Reduction Therapeutics is a nonprofit pharmaceutical company advancing harm reduction therapies to promote public health. Our Mission is to prevent opioid overdose deaths by making naloxone available to everyone at a low price. A nonprofit pharmaceutical company will not be a panacea for America’s opioid crisis, nor for the ongoing struggle with the high prices of many drugs. Indeed, for-profit pharmaceutical companies are central to America’s leading role in medical innovation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Harm Reduction TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4800 Montgomery Ln, Ste 400, Bethesda, Maryland, 20814
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.harmreductiontherapeutics.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Harm Reduction Therapeutics Donates RiVive Naloxone on Overdose Awareness Day
    Harm Reduction Therapeutics Donates RiVive Naloxone on Overdose Awareness Day

    03 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/03/2939506/0/en/Harm-Reduction-Therapeutics-Marks-International-Overdose-Awareness-Day-With-Free-Donations-of-RiVive-Life-Saving-Over-The-Counter-Naloxone-Nasal-Spray.html

    GLOBENEWSWIRE
    03 Sep 2024
    Share Share
    Harm Reduction Introduces RiVive, OTC Opioid Overdose Reversal Medication
    Harm Reduction Introduces RiVive, OTC Opioid Overdose Reversal Medication

    20 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231220516102/en

    BUSINESSWIRE
    20 Dec 2023
    Share Share
    US FDA approves second over-the-counter opioid overdose reversal drug
    US FDA approves second over-the-counter opioid overdose reversal drug

    29 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-second-over-the-counter-opioid-overdose-reversal-drug-2023-07-28/

    REUTERS
    29 Jul 2023
    Share Share
    Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma
    Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma

    21 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230321005830/en

    BUSINESSWIRE
    21 Mar 2023
    Share Share
    Harm Reduction Therapeutics' NDA for RiVive™ OTC Naloxone Nasal Spray
    Harm Reduction Therapeutics' NDA for RiVive™ OTC Naloxone Nasal Spray

    26 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/harm-reduction-therapeutics-new-drug-application-for-rivive-over-the-counter-naloxone-nasal-spray-accepted-and-granted-priority-review-by-fda-301710002.html

    PRNEWSWIRE
    26 Dec 2022
    Share Share
    Naloxone Initiates a Rolling Submission of its NDA to U.S.FDA for RiVive
    Naloxone Initiates a Rolling Submission of its NDA to U.S.FDA for RiVive

    11 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/over-the-counter-naloxone-one-step-closer-as-harm-reduction-therapeutics-initiates-a-rolling-submission-of-its-new-drug-application-nda-to-us-food-and-drug-administration-for-rivive-3-0-mg-intranasal-naloxone-for-emergency--301645959.html

    PRNEWSWIRE
    11 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search